👁️8,962
GitHubLinkedIn
AI in Healthcare and Science5 min read821 words

🚀 Cryptocurrency - Market Impacts and Decentralized Healing

👁️0reads (human + AI)🤖0AI ingestions

🚀 Cryptocurrency - Market Impacts and Decentralized Healing

This article discusses the recent market activity of Bitcoin and Ethereum and explores their potential impact on decentralized science and trauma care. It also includes commentary from Vitalik Buterin and Adam Draper.

Key Points:

• Bitcoin and Ethereum's market fluctuations influence the broader cryptocurrency landscape.

• The evolution of Ethereum may significantly impact decentralized science and trauma care initiatives.

• Decentralized approaches offer potential benefits in healthcare accessibility and affordability.

🔗 Resources:

SpectruthAI ↗ - Analysis of market trends

Vitalik Buterin ↗ - Ethereum co-founder

Adam Draper ↗ - Venture capitalist

Image

Image


🤖 Oncology - Zongertinib in HER2-Positive NSCLC

This article summarizes the FDA approval of zongertinib for treating previously treated advanced HER2-positive non-small cell lung cancer (NSCLC), based on data from the Beamion-LUNG 1 study.

Key Points:

• Zongertinib demonstrated a high response rate in a Phase 1b clinical trial.

• The drug showed durable responses and efficacy in treating intracranial disease.

• The most common side effect was diarrhea, with no instances of interstitial lung disease (ILD).

🔗 Resources:

NEJM ↗ - New England Journal of Medicine

Image

Image


💡 Workplace Trends - Downsides of On-Site Work

This article outlines several drawbacks associated with working on-site, focusing on the negative impacts on health and well-being.

Key Points:

• Commuting increases stress and may elevate cardiovascular disease risk.

• Exposure to germs in shared spaces increases infection rates.

• Reduced sleep due to earlier wake times for commutes negatively affects health.

• Less time for meal preparation can lead to unhealthy food choices.


🤖 AI in Business - GPT-5 Adoption

This article discusses the widespread adoption of GPT-5 by businesses, highlighting its transformative potential and citing several key examples.

Key Points:

• Over 5 million businesses currently utilize OpenAI technologies.

• GPT-5 represents a significant advancement for these businesses.

• Companies like Amgen, BBVA, Oscar, and the US federal government are leveraging GPT-5 for various applications.


🤖 AI in Cybersecurity - DeepSig at ISAC Strategy Summit

This article announces DeepSig's presentation at the ISAC Strategy Summit 2025, focusing on the role of AI in Information Sharing and Analysis Centers (ISACs).

Key Points:

• DeepSig will present at the ISAC Strategy Summit 2025.

• The presentation will address the role of AI in ISACs.

• The event is organized by FutureG, in partnership with George Mason University and MITRE.

🔗 Resources:

DeepSig ↗ - AI solutions for cybersecurity

Image

Image


🤖 AI in Healthcare - AI and Advanced Imaging

This article highlights the potential of combining AI with advanced imaging to improve healthcare accessibility and quality, featuring commentary from Adrian Mendes, CEO of Perimeter Med.

Key Points:

• Integrating AI with advanced imaging can enhance the adoption of medical technologies.

• This combination can lead to improved quality of care for a wider patient population.

• Performance claims for AI solutions are subject to FDA evaluation.

🔗 Resources:

Perimeter Med ↗ - AI solutions for healthcare

Adrian Mendes ↗ - CEO, Perimeter Med

Image

Image


🤖 Oncology - Trastuzumab Deruxtecan Update

This article shares an update on the DESTINY-Breast06 clinical trial, focusing on the use of Trastuzumab Deruxtecan in treating hormone receptor-positive, unresectable or metastatic breast cancer.

Key Points:

• Dr. Paolo Tarantino shared a key update on DESTINY-Breast06.

• The trial investigates Trastuzumab Deruxtecan for a specific type of breast cancer.

Image

Image


🚀 AI - PanelPicker Submission for SXSW 2026

This article announces Owkin Science's PanelPicker submission for SXSW 2026, focusing on "Agentic AI and the Rise of Biological Superintelligence".

Key Points:

• Owkin Science submitted a panel proposal for SXSW 2026.

• The proposal is titled "Agentic AI and the Rise of Biological Superintelligence".

• Public voting is open to help select the panel.

🔗 Resources:

SXSW ↗ - South by Southwest

Image

Image


🚀 Biotech - Iambic AI at KeyBanc Tech Leadership Forum

This article announces Iambic CEO Tom Miller's participation at the KeyBanc Tech Leadership Forum, discussing their AI drug discovery platform and models.

Key Points:

• Tom Miller, Iambic CEO, will present at the KeyBanc Tech Leadership Forum.

• The presentation will cover Iambic's NeuralPLexer and Enchant models.

• Updates on their collaboration with Revolution Medicines will also be shared.

Image

Image


🤖 Radiology - AI and Enhanced Radiologist Capabilities

This article discusses how AI is enhancing radiologists' capabilities, enabling them to exceed the standard of care. Commentary is included from Jason Poff, MD.

Key Points:

• AI enhances radiologists' speed and scale of analysis.

• Combining AI with radiologist expertise unlocks new possibilities for patient care.

• Leveraging AI helps exceed the standard of care in radiology.

Image

Image


⭐️ Support

If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.


Related AI in Healthcare and Science Breakdowns

Drix10
Written by Drix10

Co founder @ PartPilot | 1 x Acquired Founder | Canopy @ f.inc | Cybersec @ DSU | 2x International Hackathon 🏆. Read more on drix10.com.